RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Akshay Sood to Carcinoma, Renal Cell

This is a "connection" page, showing publications Akshay Sood has written about Carcinoma, Renal Cell.
Connection Strength

1.768
  1. Sood A, Jeong W, Barod R, Bahnson E, Kirura P, Abdollah F, Bhandari M, Bahnson R, Menon M. Robot-assisted hepatic mobilization and control of suprahepatic infradiaphragmatic inferior vena cava for level 3 vena caval thrombectomy: An IDEAL stage 0 study. J Surg Oncol. 2015 Dec; 112(7):741-5.
    View in: PubMed
    Score: 0.509
  2. Rakic I, Rakic N, Stephens A, Corsi N, Davis M, Tinsley S, Butaney M, Arora S, Sood A, Autorino R, Rogers C, Abdollah F. Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: A nationwide cohort analysis. Urol Oncol. 2023 10; 41(10):435.e1-435.e9.
    View in: PubMed
    Score: 0.222
  3. Jamil M, Hanna R, Sood A, Corsi N, Modonutti D, Keeley J, Etta P, Novara G, Patel A, Rogers C, Abdollah F. Renal Tumor Size and Presence of Synchronous Lung Metastasis at Time of Diagnosis: Implications for Chest Imaging. Urology. 2021 12; 158:110-116.
    View in: PubMed
    Score: 0.192
  4. Jamil ML, Keeley J, Sood A, Dalela D, Arora S, Peabody JO, Trinh QD, Menon M, Rogers CG, Abdollah F. Long-term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort. Eur Urol. 2020 02; 77(2):277-281.
    View in: PubMed
    Score: 0.171
  5. Arora S, Sood A, Dalela D, Tang HJ, Patel A, Keeley J, Trinh QD, Rogers CG, Menon M, Abdollah F. Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases. Eur Urol. 2019 02; 75(2):352-353.
    View in: PubMed
    Score: 0.160
  6. Abdollah F, Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD, Menon M, Rogers C. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018 03; 121(3):345-347.
    View in: PubMed
    Score: 0.148
  7. Schmid M, Krishna N, Ravi P, Meyer CP, Becker A, Dalela D, Sood A, Chun FK, Kibel AS, Menon M, Fisch M, Trinh QD, Sun M. Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol. 2016 07; 34(7):293.e1-293.e10.
    View in: PubMed
    Score: 0.133
  8. Schmid M, Abd-El-Barr AE, Gandaglia G, Sood A, Olugbade K, Ruhotina N, Sammon JD, Varda B, Chang SL, Kibel AS, Chun FK, Menon M, Fisch M, Trinh QD. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma. Urol Oncol. 2014 Nov; 32(8):1259-66.
    View in: PubMed
    Score: 0.119
  9. Antczak C, Trinh VQ, Sood A, Ravi P, Roghmann F, Trudeau V, Chang SL, Karakiewicz PI, Kibel AS, Krishna N, Nguyen PL, Saad F, Sammon JD, Sukumar S, Zorn KC, Sun M, Trinh QD. The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis. J Urol. 2014 Jun; 191(6):1678-84.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support